Trailing-twelve-month (TTM) revenue is $66.17 Million with a year-over-year growth of +101.28%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $8,955,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-06 |
| Q4 FY2025Period ended 2025-12-31 | $44,853,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-24 |
| Q1 FY2026Period ended 2026-03-31 | $8,315,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-11 |
| Q2 FY2026Period ended 2026-06-30 | $4,050,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-05 |
| TTM revenue | $66,173,000 |
Current P/S: $4,035,530,625 market capitalization ÷ $66,173,000 TTM revenue = 60.98x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T14:20:17.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $4.05M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T14:20:23.389Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|
| License | $21M | $696,000 | $969,000 | $1M | $47M |
| Milestone Payments | $8M | $900,000 | $2M | $2M | $1M |
| Research Fees |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|
| CANADA | $353M | $484M | $36M | $26M | $64M |
| UNITED STATES | $22M | $1M | $2M | $3M | $11M |
$66.17M
$66.17 Million
+101.28%
vs. $32.88M a year ago (TTM)
(31.78%)
5 Year compound annual growth rate
1 Year
+101.28%
3 Year
+10.42%
5 Year
(31.78%)
10 Year
N/A
15 Year
N/A
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $75.13M | +$46.30M | +160.56% |
| 2024 | $28.83M | ($9.19M) | (24.17%) |
| 2023 | $38.02M | ($447.40M) | (92.17%) |
| 2022 | $485.42M | +$110.22M | +29.38% |
| 2021 | $375.20M | +$142.05M | +60.92% |
| 2020 |
TTM Growth
+101.28%
3-Year CAGR
+10.42%
5-Year CAGR
(31.78%)
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 26 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T14:20:23.389Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $41M |
| $36M |
| $26M |
| $27M |
| Royalty | $327M | $443M | $0 | N/A | N/A |
|---|
| $233.16M |
| +$221.54M |
| +1907.88% |
| 2019 | $11.61M | +$2.78M | +31.49% |
